Bando Chemical Industries Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	17,851	17,715	17,935	16,770	18,837	18,863
Cash & Short-Term Investments	17,851	17,715	17,935	16,770	18,837	18,863
Cash Growth	0.42%	-1.23%	6.95%	-10.97%	-0.14%	30.15%
Accounts Receivable	25,007	22,978	23,329	21,942	22,486	20,467
Other Receivables	68	380	104	649	50	31
Receivables	25,075	23,358	23,433	22,591	22,536	20,498
Inventory	20,661	19,530	19,218	18,720	16,232	13,038
Prepaid Expenses	-	486	484	515	441	409
Other Current Assets	2,004	2,307	2,486	1,874	1,154	852
Total Current Assets	65,591	63,396	63,556	60,470	59,200	53,660
Property, Plant & Equipment	31,502	30,532	32,545	32,521	32,954	32,880
Long-Term Investments	11,870	22,190	21,013	16,977	14,939	16,202
Goodwill	1,181	1,175	4,589	4,582	4,581	8,601
Other Intangible Assets	2,506	2,748	3,188	3,602	3,947	4,413
Long-Term Deferred Tax Assets	711	647	727	814	755	521
Other Long-Term Assets	12,338	5	4	5	5	5
Total Assets	125,699	120,693	125,622	118,971	116,381	116,282
Accounts Payable	19,862	18,098	18,778	16,990	16,050	14,070
Accrued Expenses	-	5,052	4,833	4,497	5,205	3,163
Short-Term Debt	-	4,900	4,000	1,332	1,843	3,299
Current Portion of Long-Term Debt	2,700	450	1,350	6,650	1,750	4,712
Current Income Taxes Payable	1,327	872	1,251	841	1,807	710
Other Current Liabilities	7,485	1,920	2,246	1,859	1,865	1,704
Total Current Liabilities	31,374	31,292	32,458	32,169	28,520	27,658
Long-Term Debt	-	1,787	2,237	3,587	10,237	11,987
Pension & Post-Retirement Benefits	923	880	753	705	651	751
Long-Term Deferred Tax Liabilities	2,377	1,895	1,859	1,628	1,085	1,654
Other Long-Term Liabilities	2,126	2,339	2,805	2,870	3,460	3,470
Total Liabilities	36,800	38,193	40,112	40,959	43,953	45,520
Common Stock	10,951	10,951	10,951	10,951	10,951	10,951
Additional Paid-In Capital	2,911	2,921	2,936	3,112	3,075	3,075
Retained Earnings	63,471	59,418	61,039	60,380	56,480	55,857
Treasury Stock	-5,664	-3,678	-1,692	-3,577	-2,577	-1,622
Comprehensive Income & Other	16,974	12,519	11,929	6,790	4,204	2,230
Total Common Equity	88,643	82,131	85,163	77,656	72,133	70,491
Minority Interest	256	369	347	356	295	271
Shareholders' Equity	88,899	82,500	85,510	78,012	72,428	70,762
Total Liabilities & Equity	125,699	120,693	125,622	118,971	116,381	116,282
Total Debt	2,700	7,137	7,587	11,569	13,830	19,998
Net Cash (Debt)	15,151	10,578	10,348	5,201	5,007	-1,135
Net Cash Growth	43.94%	2.22%	98.96%	3.88%	-	-
Net Cash Per Share	365.23	249.65	238.69	118.13	111.27	-24.92
Filing Date Shares Outstanding	40.75	41.73	42.9	43.5	44.44	45.57
Total Common Shares Outstanding	40.75	41.8	42.9	43.5	44.52	45.57
Working Capital	34,217	32,104	31,098	28,301	30,680	26,002
Book Value Per Share	2175.16	1964.71	1985.06	1785.23	1620.18	1546.92
Tangible Book Value	84,956	78,208	77,386	69,472	63,605	57,477
Tangible Book Value Per Share	2084.68	1870.86	1803.78	1597.09	1428.63	1261.33
Order Backlog	-	12,866	11,587	11,540	14,081	10,324

Source: S&P Global Market Intelligence. Standard template. Financial Sources.